| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 01/16/2002 | CN1077884C Process for prepn. of urea |
| 01/15/2002 | CA2054209C Antihyperlipidemic and antiatherosclerotic urea compounds |
| 01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002513A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2001052900A3 Novel orthogonally protected amino acid chelators for biomedical applications |
| 01/10/2002 | WO2001042192A3 Vla-4 integrin antagonists |
| 01/10/2002 | US20020004612 Reacting ammonia and carbon dioxide |
| 01/10/2002 | US20020004608 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004237 Genetically engineered microorganism which generates endotoxin; for use in biological pest control |
| 01/10/2002 | CA2414881A1 Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 01/10/2002 | CA2410972A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410680A1 Compounds to treat alzheimer's disease |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1170288A2 Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists |
| 01/09/2002 | EP1170284A2 Urea synthesis process and apparatus |
| 01/09/2002 | EP1169312A2 Glucokinase activators |
| 01/09/2002 | EP1169308A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils |
| 01/09/2002 | EP1169303A2 Novel aryl-chloro-ethyl ureas |
| 01/09/2002 | EP1169301A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 01/09/2002 | CN1330649A Herbicidal-3-[benzo(ox/thi)azol-7-yl)-1H-pyrimidine-2,4-diones |
| 01/09/2002 | CN1077568C Phenoxyphenyl cyclopentenyl hydroxyureas |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/03/2002 | WO2002000612A1 Glucagon antagonists/inverse agonists |
| 01/03/2002 | US20020002281 Method of preparing amino carboxylic acids |
| 01/03/2002 | US20020002190 Antidiabetic agents increasing the expression of glucokinase (GK) to improve glucose tolerance; increase in glucose exposure coupled through GK in beta-cells to increase insulin secretion and in hepatocytes to increase glycogen deposition |
| 01/03/2002 | DE10030891A1 New 3,4-dihydroxybenzyl-substituted carbonic acid derivatives are antioxidants and radical scavengers useful e.g. for preventing skin aging or protecting cosmetic, dermatological or foodstuff compositions against oxidation |
| 01/03/2002 | CA2411552A1 Glucagon antagonists/inverse agonists |
| 01/02/2002 | EP1167356A2 Wet adhesion monomer and derived copolymers for latex paints |
| 01/02/2002 | EP1165533A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/02/2002 | EP1107948A4 An improved synthesis of 3-hydroxy-4-amino-benzonitrile |
| 01/02/2002 | EP0808310B1 3-(4-cyanophenyl)uracils |
| 01/02/2002 | CN1329591A Method of introducing melamine off-gases into urea plant |
| 01/02/2002 | CN1077101C 2-chloro-3,5-bis (trifluoromethyl)phenyl benzoyl urea derivative and process for preparing same |
| 01/01/2002 | US6334984 Divider horizontal baffle over cross section of shell |
| 01/01/2002 | CA2093789C Bi-aromatic compounds and their use in human and veterinary medicine and in cosmetic preparations |
| 12/27/2001 | WO2001098256A1 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 12/27/2001 | WO2001098235A2 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
| 12/27/2001 | US20010056205 3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 12/25/2001 | US6333358 Aryloxyaniline derivatives |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | WO2001051456A3 Antibacterial agents |
| 12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/19/2001 | EP1164126A1 Salicylic acid hydrazide derivatives, process and intermediates for their preparation, agents containing them and their use for combatting damaging fungi |
| 12/19/2001 | EP1163195A1 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 12/19/2001 | CN1327443A Substituted anilides |
| 12/13/2001 | WO2001094357A1 Antitumoral compounds |
| 12/13/2001 | WO2001094301A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use |
| 12/13/2001 | WO2001094300A1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
| 12/13/2001 | CA2410409A1 Antitumoral compounds |
| 12/12/2001 | EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 12/12/2001 | EP1161421A1 Inhibitors of protein tyrosine phosphatase |
| 12/12/2001 | EP1161415A2 N-cyanomethylamides as protease inhibitors |
| 12/12/2001 | EP1161233A2 Lxr modulators |
| 12/12/2001 | CN1325845A Solidized hybridized vinyl ether containing electron providing compound |
| 12/11/2001 | US6329395 Urea derivatives for treating an eating disorder or diabetes comprising administering an effective amount of a compound of claim 1 to a mammal |
| 12/11/2001 | CA2205033C Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
| 12/06/2001 | WO2001092229A1 TNF-α PRODUCTION INHIBITORS |
| 12/06/2001 | WO2001092218A2 Polyamine analogues as therapeutic and diagnostic agents |
| 12/06/2001 | WO2001092213A2 Excitatory amino acid receptor modulators |
| 12/06/2001 | WO2001092210A1 Compounds for modulating the rage receptor |
| 12/06/2001 | US20010049374 Amidino derivatives of quinoline and naphthalene |
| 12/06/2001 | US20010047963 Methods of isolating urea, urea compositions and methods for producing the same |
| 12/06/2001 | CA2736344A1 Tnf-.alpha. production inhibitors |
| 12/06/2001 | CA2599562A1 Compounds for modulating the rage receptor |
| 12/06/2001 | CA2410935A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 12/05/2001 | EP1160240A1 Guanylhydrazones for treating inflammatory conditions |
| 12/05/2001 | EP1159261A2 Antizyme modulators and their use |
| 12/05/2001 | EP1159260A1 Novel compounds and compositions as protease inhibitors |
| 12/05/2001 | EP1159258A1 Amide compounds for the potentiation of cholinergic activity |
| 12/05/2001 | EP1158985A1 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 12/05/2001 | EP0636026B1 Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor |
| 12/05/2001 | CN1325376A Novel compounds and medicinal use thereof |
| 12/05/2001 | CN1324909A Electronic donor compound capable of solidifying |
| 12/05/2001 | CN1075807C Iminooxymethylene anilides, process and intermediate products for preparing the same and pesticides containing the same |
| 11/29/2001 | WO2001090051A1 Phenylglycine derivatives |
| 11/29/2001 | US20010047111 Precipitating or crystallizing a salt from solution; suitable as intermediates for large scale production of enzyme inhibitors, e.g. hydroxyethylamine, hydroxyethylurea and hydroxyethylsulfonamide |
| 11/28/2001 | EP1158008A2 Curable hybrid electron donor compounds containing vinyl ether |
| 11/28/2001 | EP1157985A1 Para- substituted phenylene derivatives and their use as integrin antagonists |
| 11/28/2001 | EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy |
| 11/22/2001 | WO2001087840A1 Propanoic acid derivatives as integrin receptor antagonists |
| 11/22/2001 | WO2000056681A9 Thiourea and urea liquid-phase combinatorial libraries: synthesis and apoptosis induction |
| 11/21/2001 | EP1156034A2 Curable electron donor compounds |
| 11/21/2001 | EP1155677A2 Methods and compositions for inhibiting free radical polymerization in skin and hair |
| 11/21/2001 | EP1154764A1 Epoxide hydrolase complexes and methods therewith |
| 11/21/2001 | CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 11/20/2001 | US6320054 Thiazole derivatives |
| 11/20/2001 | US6320050 2-substituted phenyl-3-cycloalkyl substituted n-heteroaromatic propionamides; used to increase insulin secretion in the treatment of type ii diabetes. |
| 11/20/2001 | US6319930 Substituted dimeric compounds |
| 11/18/2001 | CA2347902A1 Curable electron donor compounds |
| 11/18/2001 | CA2347901A1 Curable hybrid electron donor compounds containing vinyl ether |
| 11/15/2001 | WO2001085706A1 Substituted phenylacetamides and their use as glucokinase activators |
| 11/15/2001 | WO2001085681A2 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 11/14/2001 | CN1322194A Substituted phenyl derivatives, their preparation and use |